Dewan Rakyat: Ozempic, Mounjaro antara 240 permohonan rawatan obesiti, diabetes diluluskan KKM
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
KUALA LUMPUR – A total of 240 applications for treatment using drugs to control type 2 diabetes and obesity were approved by the Ministry of Health (MOH) for the period from January to September. Health Minister Datuk Seri Dr. Dzulkefly Ahmad said the approval involved the use of drugs in the GLP-1 receptor agonist group including Ozempic and Mounjaro, with a total cost of RM2.56 million. He said, ...
KUALA LUMPUR: The government has not provided special allocations for the treatment of obesity and diabetes using drugs such as Ozempic and Mounjaro in the 2026 Budget. Health Minister Datuk Seri Dr. Dzulkefly Ahmad said that patients who needed the treatment could previously obtain it through the Specially Approved Medicines (UKK) mechanism using the existing allocations of the Ministry of Health (KKM). He said that a total of 240 applications …
Dewan Rakyat: Ozempic, Mounjaro antara 240 permohonan rawatan obesiti, diabetes diluluskan KKM
KUALA LUMPUR, 2 Nov: Sebanyak 240 permohonan rawatan menggunakan ubat bagi membantu mengawal diabetes jenis dua dan obesiti diluluskan Kementerian Kesihatan (KKM) bagi tempoh Januari hingga September lepas.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
